SpineGuard specializes in the design, development, and marketing of medical devices intended to improve the safety of spinal surgery. The group is developing DSG® digital technology for real-time surgical guidance without X-rays to improve the safety and simplify the placement of bone implants, pedicle screws, and "smart" drills. SpineGuard is extending the applications of its DSG® technology to anterior scoliosis treatment, sacroiliac joint fusion, and dental implantology.

Employees

Sector

Medical Equipment, Supplies & Distribution

Calendar

09-08 Earnings release - Q2 2026

More about the company

Quotes

Date	Price	Change
26-07-24	€0.0884	0.00%
26-07-23	€0.0884	+7.80%
26-07-22	€0.0820	0.00%
26-07-21	€0.0820	+0.12%
26-07-20	€0.0819	-2.27%

Real-time BOERSE MUENCHEN

More quotes

Income Statement and Estimates

More financial data

Market Closed - BOERSE MUENCHEN Other stock markets 16:43:52 2026-07-24 EDT			5-day change	1st Jan Change
0.0884 ^EUR	0.00%		-2.15%	-14.14%

07-08	Spineguard SA Reports Unaudited Consolidated Revenue Results for the Second Quarter and First Half of 2026	CI
07-07	Zonebourse earnings calendar for company results: July 8, 2026

Market Cap	8.36M 9.51M 7.77M 7.13M 13.4M 916M 13.61M 92.28M 36.05M 450M 35.72M 34.95M 1.56B	P/E 2024	-3.63x	P/E 2025	-3.37x
Enterprise Value	8.09M 9.21M 7.52M 6.9M 12.97M 887M 13.17M 89.35M 34.91M 436M 34.58M 33.84M 1.51B	EV / Sales 2024	2.94x	EV / Sales 2025	2.33x
Free-Float	97.68%	Yield 2024 *	-	Yield 2025	-

07-08	Spineguard SA Reports Unaudited Consolidated Revenue Results for the Second Quarter and First Half of 2026	CI
07-07	Zonebourse earnings calendar for company results: July 8, 2026
05-27	SpineGuard Secures Three Patent Applications in US	MT
05-26	SpineGuard granted three new patents in the United States
05-26	Spineguard Obtains Three New Patents for Full Protection in the United States of Its Innovative Solutions Integrating Dsg Technology	CI
04-28	SpineGuard Officially Launches Newly Cleared Curved and XS PediGuard Models, in Nanjing	CI
04-14	SpineGuard Transfers US Unit's Assets, Executes Distribution Deal with Omnia Medical	MT
04-13	SpineGuard and Omnia Medical Complete Us Asset Transfer and Enter Exclusive Distribution Agreement for Pediguard Devices	CI
04-13	Omnia Medical, LLC completed the acquisition of Spineguard, Inc. from SpineGuard SA.	CI
04-08	SpineGuard SA Auditor Raises 'Going Concern' Doubt	CI
04-08	SpineGuard SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
04-08	Danone, Eramet, Engie, LDC, Rémy Cointreau... stocks to watch today in Paris
04-07	Engie, LDC, Technip Energies... stocks to watch tomorrow in Paris

07-08	SpineGuard Announces its H1 2026 Revenue	BU
05-26	SpineGuard Obtains Three New Patents for Full Protection in the U.S. of Its Innovative Solutions Integrating DSG Technology	BU
04-28	SpineGuard : Official launch of three New PediGuard® Models during the Annual Scoliosis Meeting in China	PU
04-28	SpineGuard: Official Launch of Three New PediGuard® Models During the Annual Scoliosis Meeting in China	BU
04-14	14 April 2026 – 10H00 CET: SpineGuard note by BioStrategic Research (in english)	PU

SpineGuard Stock BOERSE MUENCHEN

Stocks

6W5

FR0011464452

Medical Equipment, Supplies & Distribution

Valuation: SpineGuard

Chart: SpineGuard

Latest news : SpineGuard

Analysts' recommendations: SpineGuard

Press Releases: SpineGuard

News in other languages: SpineGuard

Quotes and Performance

Course Extremes

Managers and Directors: SpineGuard

Medical Equipment

Financials

Company Profile

Quotes

Income Statement and Estimates

07-23	SpineGuard : Bilan semestriel du contrat de liquidité contracté avec la société de bourse TSAF
07-08	SpineGuard en mesure de financer son activité jusqu'au deuxième trimestre 2027
07-08	SpineGuard annonce son chiffre d’affaires du premier semestre 2026
07-07	Agenda Zonebourse des résultats de sociétés : le 8 juillet 2026
06-10	Compte rendu de l’Assemblée Générale Mixte de SpineGuard du 10 juin 2026

1 week	+5.49%
Current month	+2.31%
3 months	-10.89%
6 months	-13.50%
Current year	-7.43%

Manager	Title	Age	Since
Pierre Jérôme CEO	Chief Executive Officer	-	2020-02-14
Anne-Charlotte Millard DFI	Director of Finance/CFO	-	2008-12-31
Thibault Chandanson CTO	Chief Tech/Sci/R&D Officer	-	2019-08-31

Director	Title	Age	Since
Stéphane Bette BRD	Director/Board Member	-	2009-01-15
Maurice Bourlion BRD	Director/Board Member	-	2009-07-01
Pierre Jérôme CHM	Chairman	-	2018-02-28

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SPINEGUARD	0.00%	-2.15%	+7.80%	-82.81%	9.49M
PENUMBRA, INC.	+0.26%	+0.13%	+38.47%	+5.31%	12.5B
GETINGE AB	+0.52%	+9.10%	+18.83%	+19.98%	6.39B
ASAHI INTECC CO., LTD.	-0.53%	-2.57%	+45.33%	+20.46%	5.5B
MINIMED GROUP, INC.	+3.06%	-0.59%	-	-	4.59B
APT MEDICAL INC.	-3.39%	-1.19%	-29.45%	+18.83%	4.47B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	-2.85%	-4.45%	-23.96%	-24.19%	4.03B
NOVOCURE LIMITED	-11.71%	+10.87%	+40.75%	-53.95%	2.32B
IMPLANTICA AG	-0.34%	-7.40%	-17.30%	+218.18%	1.71B
NAKANISHI INC.	+0.33%	+0.33%	+56.68%	-2.86%	1.55B
Average	-1.62%	+1.49%	+15.24%	+13.22%	4.78B
Weighted average by Cap.	-0.83%	+1.04%	+20.13%	+13.94%

	2024	2025
Net sales	4.65M 5.29M 4.32M 3.97M 7.45M 510M 7.57M 51.33M 20.05M 251M 19.87M 19.44M 866M	3.76M 4.28M 3.49M 3.21M 6.02M 412M 6.12M 41.49M 16.21M 203M 16.06M 15.71M 700M
Net income	-3.08M -3.51M -2.87M -2.63M -4.94M -338M -5.02M -34.03M -13.3M -166M -13.17M -12.89M -574M	-2.07M -2.35M -1.92M -1.76M -3.32M -227M -3.37M -22.83M -8.92M -111M -8.84M -8.65M -385M
Net Debt	1.82M 2.07M 1.69M 1.55M 2.92M 199M 2.96M 20.08M 7.85M 98.04M 7.77M 7.61M 339M	-265K -302K -247K -226K -425K -29.1M -432K -2.93M -1.14M -14.3M -1.13M -1.11M -49.46M

1 week	0.08	0.09
1 month	0.08	0.09
3 years	0.06	0.51
5 years	0.06	1.65